Purchases and Sales Made in Q4 2024 in Bicycle Therapeutics PLC (BCYC)
This table provides information about the institutional ownership of Bicycle Therapeutics PLC (BCYC) during Q4 2024. The information is specifically focused on institutions that hold shares of BICYCLE THERAPEUTICS plc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 06, 2025
Q4 2024
|
Assetmark, Inc
|
SELL
|
- |
-259- 17.05% |
$3.58K - $7.12K
|
1.26K
$13.1K
|
|
|
Feb 13, 2025
Q4 2024
|
Natixis
Paris, I0 |
SELL
|
- |
-437- 15.98% |
$6.03K - $12K
|
2.3K
$23.9K
|
|
|
Feb 14, 2025
Q4 2024
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-440- 0.08% |
$6.08K - $12.1K
|
554K
$5.75M
|
|
|
Feb 10, 2025
Q4 2024
|
Tocqueville Asset Management L.P.
New York, NY |
SELL
|
- |
-700- 4.55% |
$9.67K - $19.3K
|
14.7K
$153K
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-717- 8.51% |
$9.9K - $19.7K
|
7.71K
$80K
|
|
|
Jan 02, 2025
Q4 2024
|
Gamma Investing LLC
Foster City, CA |
SELL
|
- |
-1.11K- 54.74% |
$15.3K - $30.5K
|
917
$9.52K
|
|
|
Jan 30, 2025
Q4 2024
|
Ronald Blue Trust, Inc.
Brentwood, TN |
SELL
|
- |
-1.18K- 99.08% |
$16.4K - $32.6K
|
11
$114
|
|
|
Feb 14, 2025
Q4 2024
|
Silvercrest Asset Management Group LLC
New York, NY |
SELL
|
- |
-1.35K- 0.97% |
$18.7K - $37.2K
|
138K
$1.43M
|
|
|
Feb 14, 2025
Q4 2024
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-1.4K- 1.15% |
$19.3K - $38.5K
|
121K
$1.25M
|
|
|
Feb 14, 2025
Q4 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-1.65K- 20.48% |
$22.8K - $45.5K
|
6.42K
$66.6K
|
|
|
Jan 10, 2025
Q4 2024
|
Harbor Capital Advisors, Inc.
|
SELL
|
- |
-2.2K- 1.65% |
$30.4K - $60.6K
|
132K
$1.37M
|
|
|
Feb 03, 2025
Q4 2024
|
Handelsbanken Fonder Ab
|
SELL
|
- |
-2.8K- 1.28% |
$38.7K - $77K
|
216K
$2.24M
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-3.1K- 1.14% |
$42.8K - $85.3K
|
270K
$2.8M
|
|
|
Feb 14, 2025
Q4 2024
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-5.21K- 4.02% |
$71.9K - $143K
|
124K
$1.29M
|
|
|
Feb 11, 2025
Q4 2024
|
Td Asset Management Inc
|
SELL
|
- |
-5.4K- 2.44% |
$74.6K - $149K
|
216K
$2.24M
|
|
|
Feb 14, 2025
Q4 2024
|
High Vista Strategies LLC
Boston, MA |
SELL
|
- |
-15.1K- 10.83% |
$209K - $416K
|
124K
$1.29M
|
|
|
Feb 14, 2025
Q4 2024
|
Wexford Capital LP
Greenwich, CT |
SELL
|
- |
-17K- 48.74% |
$235K - $468K
|
17.9K
$186K
|
|
|
Feb 14, 2025
Q4 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-28.7K- 36.53% |
$397K - $790K
|
49.9K
$518K
|
|
|
Feb 13, 2025
Q4 2024
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-44.6K- 52.53% |
$617K - $1.23M
|
40.4K
$419K
|
|
|
Feb 14, 2025
Q4 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-56.9K- 54.01% |
$785K - $1.56M
|
48.4K
$503K
|
|
|
Feb 14, 2025
Q4 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-58.9K- 23.0% |
$813K - $1.62M
|
197K
$2.05M
|
|
|
Feb 14, 2025
Q4 2024
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-92.9K- 20.86% |
$1.28M - $2.56M
|
352K
$3.66M
|
|
|
Feb 13, 2025
Q4 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-99.7K- 41.76% |
$1.38M - $2.74M
|
139K
$1.44M
|
|
|
Feb 14, 2025
Q4 2024
|
Tybourne Capital Management (Hk) LTD
Hong Kong, K3 |
SELL
|
- |
-125K- 8.96% |
$1.73M - $3.44M
|
1.27M
$13.2M
|
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-137K- 7.95% |
$1.89M - $3.77M
|
1.59M
$16.5M
|
|
|
Feb 14, 2025
Q4 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-381K- 89.95% |
$5.25M - $10.5M
|
42.5K
$441K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-488K- 36.13% |
$6.74M - $13.4M
|
862K
$8.95M
|
|
|
Feb 14, 2025
Q4 2024
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-1.16M- 51.47% |
$16M - $31.9M
|
1.09M
$11.4M
|
|
|
Feb 14, 2025
Q4 2024
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-2.27M- 64.03% |
$31.4M - $62.5M
|
1.28M
$13.2M
|